Forma Therapeutics to discover candidates for Singapore centre
This article was originally published in Scrip
Executive Summary
Forma Therapeutics is to apply its proprietary technology to discover new compounds for Singapore's Experimental Therapeutics Centre. The financial terms of the agreement were not disclosed.